CASI: CASI Pharmaceuticals, Inc. Amount of Cash per Share

Corporate emblem and logo of CASI Pharmaceuticals Inc. (CASI)

The trend in cash per share indicates pressure stemming from testing costs and sales delays. CASI Pharmaceuticals is driving innovation in China through partnerships with foreign laboratories, yet faces intense pressure from global players and the risk of technological obsolescence. Meanwhile, the level of 0.00 represents the current value of this financial metric.

CASI (casipharmaceuticals.com) Cash per Share history from 07/04/2022 to 03/14/2026

Analytical breakdowns for CASI Pharmaceuticals

- market value and analyst target forecast:
- market capitalization information:
- cash position and cash flow details:
Comprehensive company analysis:CASI CASI Pharmaceuticals, Inc.
Core merchandise of CASI Pharmaceuticals

The market evaluates the potential of CASI Pharmaceuticals through the lens of available resources for expansion. The indicator is calculated as the ratio of total liquid assets to the number of shares outstanding. By analyzing the current liquidity per share, an investor can see the real value of reserves without accounting distortions. A decline in this metric signals either capital dilution or investments in expanding the oncology ecosystem in China. This is a critical marker of financial stability when integrating Western drugs.